HEALTH● LOWJul 24 · Jul 24, 2026, 12:58 PM
Merck signs licensing deals with companies including Viatris for new HIV pill
Seeking Alpha Tech
Merck has entered into licensing agreements with multiple companies, including Viatris, concerning a new HIV medication.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH21m agoEbola: Yobe Govt Activates Emergency Response Centres, Border SurveillanceChannels TVHEALTH22m agoEbola: Plateau reactivates isolation centres, strengthens surveillanceVanguard NigeriaHEALTH48m ago'An everyday habit': 2.5 billion lines of cocaine snorted in England per yearFrance 24 [en]HEALTH49m agoUganda imposes a 21-day quarantine on citizens returning from the Democratic Republic of CongoBBC Afrique